美國西雅圖的CTI Biophama在上世紀九十年代，根據中國醫學的這個信息，把砒霜發展成治療某一類型白血病的藥物。

CTI’s marketing of another drug, Trisenox, was the focus of one Seattle Times story in a 2014 series examining how pharmaceutical companies boost the revenue of limited-scope orphan drugs by encouraging doctors to use them for so-called ‘off-label’ or unapproved conditions. Trisenox was an arsenic compound approved by the Food and Drug Administration for treating a subset of an already rare form of leukemia

所有跟帖： 

• 當時是大新聞。張亭棟的成功例子，說明實驗設計和思路很重要。在學習先進的實驗思路和手段方麵，現在國內中醫藥界做得不錯。 -欲千北- ♂ (0 bytes) () 08/04/2019 postreply 13:46:59

• 中醫治病關鍵是思維思路，而不是具體某個藥方。西醫刻舟求劍，用某個藥方來驗證中醫是否能治癌，不是水平不足就是別有用心 -醫者意也- ♂ (0 bytes) () 08/04/2019 postreply 15:54:53

• 看來你不是刻舟求劍，懂博大精深。請問你治好了幾例癌症？治愈率多少？ -欲千北- ♂ (0 bytes) () 08/04/2019 postreply 18:37:45

• 我說了，在論壇講幹貨是沒有意義的 -醫者意也- ♂ (0 bytes) () 08/04/2019 postreply 18:59:18

• 沒有叫你說出你的治療手段，隻是問你治療效果。連博大精深的效果都不願說，怎麽回事？ -欲千北- ♂ (0 bytes) () 08/04/2019 postreply 20:09:44